CLINDAMYCIN PHOSPHATE AND TRETINOIN

Post-LOE

clindamycin phosphate and tretinoin

Teva

ANDATOPICALGEL

Approved

Jun 2015

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CLINDAMYCIN PHOSPHATE AND TRETINOIN (clindamycin phosphate and tretinoin) by Teva is 12. Approved for retinoid [epc]. First approved in 2015.

Drug data last refreshed 19h ago

Mechanism of Action

12.1 Mechanisms of Action Clindamycin [see ]. Tretinoin Although the exact mode of action of tretinoin is unknown, current evidence suggests that topical tretinoin decreases cohesiveness of follicular epithelial cells with decreased microcomedo formation. Additionally, tretinoin stimulates mitotic…

Pharmacologic Class:

Retinoid

Indications

Worked on CLINDAMYCIN PHOSPHATE AND TRETINOIN at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.